{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:34:57Z","timestamp":1767713697136,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.prp.2023.154310","type":"journal-article","created":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T09:27:44Z","timestamp":1673774864000},"page":"154310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The case of T-ALL presenting with NK phenotype after COVID-19 vaccination"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-9755","authenticated-orcid":false,"given":"Eriko","family":"Yanagida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154310_bib1","unstructured":"Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J., Arber D.A., Hasserjian R.P., Beau M.M.L., Orazi A., Sibert R. World health organization classification of tumours of haematopoietic and lymphoid tissues. In: Borowitz MJ, Chan JKC, Bene MC, Arber DA, editors. T-lymphoblastic leukemia\/lymphoma. revised 4th ed. New York: Lyon; 2017. p.209\u2013212."},{"key":"10.1016\/j.prp.2023.154310_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3343\/alm.2019.39.2.125","article-title":"T-Cell receptor rearrangements determined using fragment analysis in patients with T-acute lymphoblastic leukemia","volume":"39","author":"Kim","year":"2019","journal-title":"Ann. Lab Med"},{"key":"10.1016\/j.prp.2023.154310_bib3","unstructured":"Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J., Arber D.A., Hasserjian R.P., Beau M.M.L., Orazi A., Sibert R. World health organization classification of tumours of haematopoietic and lymphoid tissues. In: Borowitz MJ, Bene MC, Harris NL, Porwit A, Matutes E, Arber DA, editors. NK-lymphoblastic leukemia\/lymphoma. revised 4th ed. New York: Lyon; 2017. p.213."},{"key":"10.1016\/j.prp.2023.154310_bib4","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1084\/jem.178.6.1857","article-title":"Human natural killer cell committed thymocytes and their relation to the T cell lineage","volume":"178","author":"S\u00e1nchez","year":"1993","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.prp.2023.154310_bib5","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.prp.2023.154310_bib6","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1080\/21645515.2021.2008215","article-title":"Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET\/CT after adenovirus-vectored COVID-19 vaccine","volume":"17","author":"Landete","year":"2021","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.prp.2023.154310_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/RLU.0000000000003597","article-title":"COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET\/CT","volume":"46","author":"Xu","year":"2021","journal-title":"Clin. Nucl. Med"},{"key":"10.1016\/j.prp.2023.154310_bib8","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/jdv.17736","article-title":"Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination","volume":"36","author":"Panou","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.prp.2023.154310_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.798095","article-title":"Rapid progression of angioimmunoblastic T cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report","volume":"8","author":"Goldman","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.prp.2023.154310_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2023.154310_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.2008.07457.x","article-title":"The presence of CD56\/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment","volume":"144","author":"Dalmazzo","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.prp.2023.154310_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.13543","article-title":"CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy","volume":"94","author":"Fischer","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.prp.2023.154310_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2162-3619-2-10","article-title":"Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia","volume":"2","author":"Gimenes-Teixeira","year":"2013","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.prp.2023.154310_bib14","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","article-title":"Biology and clinical relevance of human natural killer cells","volume":"76","author":"Robertson","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.154310_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.prp.2023.154310_bib16","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2005-07-2797","article-title":"Expression of rearranged TCRgamma genes in natural killer cells suggests a minor thymus-dependent pathway of lineage commitment","volume":"107","author":"Veinotte","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.154310_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-065X.1998.tb01235.x","article-title":"Accessibility control of variable region gene assembly during T-cell development","volume":"165","author":"Sleckman","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.prp.2023.154310_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/smim.1997.0069","article-title":"Events that regulate differentiation of alpha beta TCR+ and gamma delta TCR+ T cells from a common precursor","volume":"9","author":"Kang","year":"1997","journal-title":"Semin Immunol."},{"key":"10.1016\/j.prp.2023.154310_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fimmu.2020.00042","article-title":"Regulation of \u03b3\u03b4 T cell effector diversification in the thymus","volume":"11","author":"Parker","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2023.154310_bib20","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.179.6.1913","article-title":"Temporal and lineage-specific control of T cell receptor alpha\/delta gene rearrangement by T cell receptor alpha and delta enhancers","volume":"179","author":"Lauzurica","year":"1994","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.prp.2023.154310_bib21","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.150.10.4244","article-title":"A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression","volume":"150","author":"Godfrey","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.prp.2023.154310_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/eji.200636503","article-title":"Beta-selection: abundance of TCRbeta-\/gammadelta- CD44- CD25- (DN4) cells in the foetal thymus","volume":"37","author":"Hager-Theodorides","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.prp.2023.154310_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106612","article-title":"Adverse prognostic impact of complex karyotype (\u22653 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)","volume":"109","author":"Genesc\u00e0","year":"2021","journal-title":"Leuk. Res"},{"key":"10.1016\/j.prp.2023.154310_bib24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood.2020007959","article-title":"IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL","volume":"137","author":"Simonin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.154310_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41379-021-00739-4","article-title":"Clinical immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group","volume":"34","author":"Weinberg","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154310_bib26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood-2016-07-692608","article-title":"Management of adults with T-cell lymphoblastic leukemia","volume":"129","author":"Marks","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.154310_bib27","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/cncr.30262","article-title":"Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia","volume":"122","author":"Short","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154310_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000489025","article-title":"Blast percentage of bone marrow aspirate on day 14 of induction chemotherapy predicts adult acute lymphoblastic leukemia treatment outcomes","volume":"139","author":"Park","year":"2018","journal-title":"Acta Haematol."},{"key":"10.1016\/j.prp.2023.154310_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.tips.2021.06.004","article-title":"Targeting natural killer cells to enhance vaccine responses","volume":"42","author":"Cox","year":"2021","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.prp.2023.154310_bib30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2020.01512","article-title":"Flattening the COVID-19 curve with natural killer cell based immunotherapies","volume":"11","author":"Market","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2023.154310_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102685","article-title":"Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: an analysis of European data","volume":"122","author":"Cari","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.prp.2023.154310_bib32","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1111\/1759-7714.14179","article-title":"Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)","volume":"12","author":"Sumi","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.prp.2023.154310_bib33","first-page":"5","article-title":"mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients","volume":"15","author":"Azzolini","year":"2022","journal-title":"Life Sci. Alliance"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:56:53Z","timestamp":1759733813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"alternative-id":["S0344033823000109"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154310","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case of T-ALL presenting with NK phenotype after COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154310"}}